Re-wilding: don't overlook humans living on the plains
SIR -Proposals made by Josh Donlan and colleagues to "re-wild" the Great Plains ("Re-wilding North America" Nature 436, 913-914; 2005) assume that if the land is void of people, it is necessarily open to exotic megafauna. As a historian of the twentiethcentury American West, I disagree, and I believe the re-wilding plan would be harmful to current environmental efforts in the area.
The human population may be sparse, but people on the plains use large areas of land to drive the economies of the towns that dot the landscape. How synthetic biology can avoid GMO-style conflicts SIR -Your News story "Synthetic biologists face up to security issues" (Nature 436, 894-895; 2005) , defines synthetic biology as the ability "to create complete genomes from scratch and to introduce new characteristics into viruses and bacteria". But the second half of this definition has already been applied for decades to genetically modified organisms (GMOs), and particularly to modified viral genomes. The present discussion about regulation of synthetic biology should carefully consider how and why GMOs are regulated, in order to avoid regulatory chaos.
The US and Canadian systems for GMO regulation are based on the properties of the organisms produced, whereas the European system is based more on techniques. The incompatibility between product-based and technique-based systems is the source of much of the transatlantic tension regarding GMOs.
North American scientists are calling for technique-based regulation of synthetic biology. But for products of synthetic biology that bear novel genes and thus are also GMOs, which type of regulation should prevail: technique-or product-based? If the former, one would quickly encounter the situation where equivalent organisms, synthetic or classic GM, would be regulated using drastically different strategies and criteria. If the latter, the most potentially dangerous products of synthetic biology would simply be regulated as GMOs. If the United States and/or Canada go forward with techniquebased regulation of synthetic biology, a minimum of coherence would require them also to shift to technique-based regulation of GMOs -a major policy change.
I believe that the first step to reassure the public about synthetic biology should be to cool the rhetoric. The present situation is reminiscent of 30 years ago, when some of the pioneers in the then-new field of genetic engineering made unrealistic claims about what was feasible; this was one of the major early sources of public uneasiness about GMOs. There should be a bit more modesty in claims both about what can be achieved by synthetic biology in the foreseeable future, and about what could be achieved by additional regulatory supervision. The British Chiropractic Association (BCA) is currently undertaking a large-scale observational study (sample size of over 50,000) to document patient outcomes after cervical spine manipulation. Final data analysis is expected in 2006, and we hope to publish the results in peer-reviewed journals.
The BCA has also, in conjunction with the Anglo-European Chiropractic College, set up a chiropractic reporting and learning system; more than 1,200 practitioners who are members of the BCA have recently received an information pack to enable them to participate in the scheme. Resulting data will be analysed at the Anglo-European Chiropractic College and outcomes will be relayed to the profession, through our newsletter, journal and website, so practitioners may learn from the experience of others.
The intention is that the scheme will, if successful, be offered to other chiropractic associations within Europe in 2006.
